NEW YORK (
CHANGE IN RATINGS, EPS
estimates, target raised at Oppenheimer. Shares of AGP now seen reaching $66. Estimates also increased, to match the company's new guidance. Outperform rating.
estimates, target boosted at Sterne Agee.Shares of ACI now seen reaching $25. Estimates also upped, given higher met coal pricing. Neutral rating.
estimates, target upped at Credit Suisse.Shares of AVT now seen reaching $34. Estimates also boosted, to match the company's new guidance. Neutral rating.
numbers upped at Oppenheimer.BEAV estimates were boosted through 2012. Company's backlog is building. Outperform rating and new $43 price target.
numbers increased at UBS.Shares of BIIB now seen reaching $132. Estimates also increased on solid 3Q performance in core products and upside from pipeline.
upgraded at JMP. BRCM was upgraded from Market Perform to Market Outperform. $42 price target. Industry checks point towards ongoing market share dominance.
estimates, target lowered at UBS.Shares of CVC now seen reaching $16. Estimates also lowered as EBITDA growth turns negative and revenue growth slows. Neutral rating.
downgraded at Sterne Agee from Buy to Neutral. $43 price target. Valuation call.
downgraded at BofA Merrill from Buy to Neutral. $127 price target. Production stalls, capex risked higher.
Chevron estimates increased at Jefferies. CVX estimates were raised through 2012. Company is leveraged to higher energy prices. Buy rating and $120 price target.
estimates, target increased at Oppenheimer.CI estimates were raised through 2012. HS acquisition should add to earnings. Outperform rating and new $58 price target.
numbers upped at Oppenheimer.CSCO estimates were boosted through 2013. Channel checks show solid business momentum. Outperform rating and new $21 price target.
estimates reduced at Jefferies through 2012. Currency and margins are hurting earnings. Hold rating and $92 price target.
numbers lowered at Jefferies.CMC estimates were cut through 2012. Earnings recovery may take longer than expected. Hold rating and new $14 price target.
Complete Production Services
downgraded at Canaccord from Buy to Hold. $33 price target. Investors can get better annualized returns in other completion names.
estimates, target boosted at ThinkEquity.Shares of CVLT now seen reaching $50. Estimates also upped, as the company is gaining market share. Buy rating.
estimates increased at UBS through 2012. Wholesale margins show some improvement. Maintain $42 price target and Neutral rating.
downgraded at Credit Suisse from Outperform to Neutral. $67 price target. Company lacks near-term catalysts.
rated new Neutral at UBS. $47 price target. Retail strategy should offset merchant decline, continued growth into '12.
numbers cut at ThinkEquity. Shares of FSLR now seen reaching $57. Estimates also lowered, given slower demand. Hold rating.
upgraded to hold at TheStreet Ratings.
Goodyear estimates increased at UBS through 2012. $22 price target. Undervalued versus near/medium term earnings power. Maintain $22 price target and Buy rating.
estimates, target boosted at Oppenheimer.HES estimates were upped through 2012. Shale development and offshore exploration are driving demand. Outperform rating.
estimates, target boosted at Credit Suisse.Shares of INTC now seen reaching $32. Estimates also upped, as emerging markets should drive growth. Outperform rating.
estimates, target raised at Morgan Stanley.Shares of IPG now seen reaching $12. Estimates also increased, given higher realized margins.
upgraded at Wedbush from Neutral to Outperform. $27 price target. Fundamentals appear to have bottomed.
upgraded to buy at TheStreet Ratings.
numbers raised at Jefferies. Shares of LPNT now seen reaching $47. Estimates also increased, given cost-cutting efforts. Buy rating.
estimates, target lowered at Keybanc.MDR estimates were cut through 2012. Company reduced its guidance. Buy rating and new $18 price target.
estimates lowered at UBS through 2013. Gross margins under pressure and need to return to explicit guidance. Buy rating.
upgraded at Dahlman to Buy. $30 price target. Recent management changes should help the company.
National Oilwell Varco
numbers boosted at Morgan Stanley.Shares of NOV now seen reaching $79. Estimates also upped, given solid rig demand. Equal-weight rating.
numbers increased at Morgan Stanley.NWL estimates were raised through 2013. Company is cutting costs and has better earnings visibility.
rated new Neutral at UBS. $19 price target. Ad recovery moderating.
downgraded at BofA Merrill from Buy to Underperform. $24 price target. Weaker volume outlook and limited upside to chlor-alkali prices.
estimates cut at Credit Suisse through 2013. Domestic business remains slow. Outperform rating and new $33 price target.
estimates, target cut at Credit Suisse. Shares of RSH now seen reaching $13. Estimates also reduced, Company faces lower near-term demand. Neutral rating.
rated new Neutral at JP Morgan. Valuation call, based on a $22 price target. Consensus expectations appear conservative.
downgraded at Sterne Agee from Buy to Neutral. $58 price target. Company is leveraged to the move toward SSD.
estimates, target reduced at Jefferies.Shares of TEN now seen reaching $43. Estimates also cut, as the company is realizing lower margins. Buy rating.
Varian Medical Systems
numbers increased at UBS.Shares of VAR now seen reaching $62. Estimates also increased on higher revenues. Neutral rating.
numbers lowered at Evercore.DIS estimates were cut through 2012. Cable network and studio growth could fall short of expectations. Overweight rating and new $42 price target.
rated new Neutral at JP Morgan. Valuation call, based on a $76 price target.
This article was written by a staff member of TheStreet.